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Hemodynamic Patterns for Symptomatic
Presentations of Severe Aortic Stenosis
Sung-Ji Park, MD, PHD,* Maurice Enriquez-Sarano, MD,† Sung-A Chang, MD, PHD,*
Jin-Oh Choi, MD, PHD,* Sang-Chol Lee, MD, PHD,* Seung Woo Park, MD, PHD,*
Duk-Kyung Kim, MD, PHD,* Eun-Seok Jeon, MD, PHD,* Jae K. Oh, MD*†
Seoul, Korea; and Rochester, Minnesota
O B J E C T I V E S The aim of this study was to investigate intracardiac hemodynamic idiosyncrasies
responsible for various presentations of severe aortic stenosis (AS).
B A C KG ROUND Syncope, dyspnea, and chest pain are well-established indications for aortic valve
replacement in patients with severe AS. Patients’ survival is limited once they develop symptoms from AS,
and survival depends on what type of symptoms a patient develops. We hypothesized that there would be
a relationship between the type of AS symptoms and intracardiac hemodynamics as well as AS severity.
METHOD S We analyzed 498 patients (men: 58.4%, 66 12 years of age) with severe AS and normal
left ventricular ejection fraction from 2003 to 2009 who had comprehensive echocardiography
examination for AS. The study population was divided into 4 groups based on presenting symptom(s)
(341 in group I, asymptomatic; 15 in group II, syncope; 110 in group III, dyspnea; 32 in group IV, chest
pain). Echocardiographic measurements for cardiac structure, function, and intracardiac hemodynamic
parameters were compared among these 4 groups.
R E S U L T S Mean aortic valve pressure gradient and aortic valve area were 57.1  15.2 mm Hg and
0.74  0.19 cm2, respectively. AS severity based on mean gradient and aortic valve area was similar
among 4 groups. Compared with the asymptomatic group, symptomatic patients were older and had
lower cardiac output, and higher E/e’ ratio while having a similar aortic valve area and gradient. Group
II (syncope) displayed smaller LV dimension, stroke volume, cardiac output, left atrial volume index, and
E/e’ ratio. Conversely, group III (dyspnea) was found to have the worst diastolic function with largest left
atrial volume index and highest E/e’ ratio.
CONC L U S I O N S Among patients with severe AS, their symptoms are often linked to speciﬁc
hemodynamic patterns associated with AS: smaller left ventricular cavity and reduced output for
syncope versus more advanced diastolic dysfunction for dyspnea. Hence, comprehensive intracardiac
hemodynamics including diastolic function and stroke volume need to be evaluated in addition to aortic
valve area and pressure gradient for assessment of AS. (J Am Coll Cardiol Img 2013;6:137–46) © 2013
by the American College of Cardiology Foundation
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138ortic stenosis (AS) is the most common val-
vular heart disease in the elderly character-
ized by fixed aortic valve narrowing, left
ventricular (LV) remodeling with hyper-
trophy, and progressive diastolic dysfunction (1).
The cardinal manifestations of AS include syncope,
chest pain, and dyspnea. It has been well described
that patients’ survival is limited once they develop
symptoms from AS, and survival after the onset of
a symptom depends on what type of symptoms a
patient develops (2). Therefore, the onset or pres-
ence of these symptoms are the class I indication for
See page 147
surgical indication, but without any distinction
among symptoms. Because the survival duration
without aortic valve replacement depends on the
type of symptoms in severe AS, we hypothesized
that there would be a relationship between the type
of AS symptoms and intracardiac hemodynamics as
well as the severity of AS. The fact that patients
with dyspnea have the worst prognosis
suggests that these patients do have the
worst intracardiac hemodynamics and
more severe AS than do the patients with
other symptoms (2). However, little is
known about the relationship between AS
symptoms and intracardiac hemodynam-
ics. Nor do we understand why specific
symptoms develop and whether the sever-
ity of AS (within the severe AS category)
or the cardiac response to AS determines the
occurrence of specific symptoms. The objective of
this study was to assess how a particular symptom in
patients with severe AS is related to intracardiac as
well as aortic valvular hemodynamics.
M E T H O D S
Study population. A prospective registry com-
enced in 2003 and using a standard case report
orm has included all consecutive patients with AS
ndergoing echocardiography at a major tertiary
ardiac and vascular center in Korea. Clinical and
chocardiographic follow-up data on study patients
ere collected annually and entered into the data-
ase. Subjects who had severe AS and normal LV
jection fraction (50%) in transthoracic echocar-
iogram were included in our study. Severe AS was
efined as aortic valve area (by the continuity
exquation) 1 cm2 as previously published (3). (Exclusion criteria included previous aortic valve
replacement, concomitant other valvular disease of
moderate or severe severity, coronary artery disease
defined as 50% narrowing in at least 1 coronary
artery in an angiogram, history of myocardial in-
farction, acute coronary syndrome, and end-stage
renal disease on chronic dialysis. The study was
approved by the regional ethics committee. From
2003 to 2009, 498 patients (mean age: 66  12
years of age) with severe AS met the criteria for
inclusion in this study (Fig. 1).
All patients’ medical records written by the pri-
mary physician(s) were carefully reviewed by 1
cardiologist. The study population was divided into
4 groups based on their predominant presenting
symptom at baseline (group I, asymptomatic; group
II, syncope; group III, dyspnea; group IV, chest
pain). Patients with pre-syncope were also included
in group II. Patients with chest heaviness or chest
discomfort were included in group IV.
Echocardiographic evaluation. Comprehensive trans-
horacic echocardiography (M-mode, 2-dimensional,
nd Doppler) was performed using commercially
vailable equipment (Vivid 7, GE Medical Systems,
ilwaukee, Wisconsin; Acuson 512, Siemens
edical Solutions, Mountain View, California; or
onos 5500, Philips Medical Systems, Andover,
assachusetts). Maximal aortic jet velocity was
ecorded from the apical, right parasternal, or su-
rasternal window that yielded the highest-velocity
ignal. End diastole was defined as the frame with
he largest cavity area near the QRS interval and
nd systole as the frame with the smallest cavity
rea. LV end-diastolic volume, LV end-systolic
olume, and LV ejection fraction were calculated
rom 2-dimensional recordings using the modified
iplane Simpson method (4). Relative wall thick-
ess and LV mass were calculated as described
reviously (5,6). Left atrial (LA) volume was as-
essed by the modified biplane area-length method
nd was indexed to body surface area. LV stroke
olume was derived as the cross-sectional area of
he LV outflow tract time-velocity integral of the
V outflow tract flow by pulse wave Doppler (7).
ardiac output was calculated as the product of LV
troke volume and heart rate. Mean aortic gradient
nd aortic valve area (by the continuity equation)
ere obtained as previously reported (8) and de-
cribed in the guidelines of the American Society of
chocardiography (7,9). LV stroke work loss was
xpressed as a percentage and calculated as 100 
ean transvalvular aortic valve pressure gradient/A B B R E V I A T I O N S
A N D A C R O N YM S
AS aortic stenosis
LA left atrial
LAVI left atrial volume ind
LV left ventricularmean transvalvular aortic pressure gradient  sys-
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139tolic blood pressure) (10). Early diastolic mitral
inflow velocity (E) was measured using the pulsed
wave Doppler. The tissue Doppler-derived early dia-
stolic mitral annular velocity (e=) was measured from
the septal corner of the mitral annulus in the apical
4-chamber view. Deceleration time of early transmi-
tral flow velocity was also measured. As an index of
LV filling pressure, E/e= was calculated. The average
of 3 consecutive Doppler signals was used.
Statistical analysis. Continuous variables are listed as
ean  SD or median (Q1, Q3). Categorical variables
re presented as frequencies and group percentages.
Differences between asymptomatic groups and
ymptomatic groups were assessed using Wilcoxon
ank sum test for comparing 2 independent samples.
Differences among 4 groups were assessed using
ruskal-Wallis test for continuous variables and
hi-square test or Fisher exact test for categorical
ariables. For the comparison of the continuous
ariables among groups according to presenting
ymptoms, we used 1-way analysis of variance. Post
oc pairwise comparisons were adjusted for multi-
le comparisons using the Dunnett significant dif-
erence method. We assessed univariate regression
ith presence of symptoms or presence of dyspnea
s a nominal dependent variable and other param-
ters as independent variables. Multiple logistic
egression analysis was used to assess independent
eterminants of presence of symptoms and presence
f dyspnea. For multivariate analysis, significant p
alue variables in univariate analysis and other
mportant clinical variables irrespective of their
nivariate p value were included in the model.
eneralized logit model for nominal response data
Aortic va
Baseline clinic
Symptomatic Severe AS
(n=157, 31.5%)
Dyspnea
(n=110, 22.1%)
Syncope
(n=15, 3.0%)
Figure 1. Description of Study Population
AS  aortic stenosis; EF  ejection fraction; LV  left ventricular.as used to assess the association of presence ofyspnea and clinical and echocardiographic param-
ters among 4 different groups. Group III (dyspnea)
erved as the reference group.
All reported p values were 2-sided, and a p value
0.05 was considered statistically significant. SPSS
version 15.0, SPSS Inc., Chicago, Illinois) was
sed for all statistical analyses. The authors had full
ccess to the data and take responsibility for its
ntegrity. All authors have read and agree to the
anuscript as written.
R E S U L T S
Clinical and echocardiographic characteristics. The
otal population included 498 patients (291 were
en [58.4%], with a mean age of 66  12 years) of
hom 157 were symptomatic and 341 were asymp-
omatic. Baseline characteristics of total patients are
hown in Table 1. In the total cohort, mean LV
jection fraction was 64.6  6.7% and mean aortic
alve area (AVA) was 0.74  0.19 cm2. When the
symptomatic patients were compared with the
asymptomatic patients, the symptomatic group was
older. The severity of AS, as determined by AVA,
peak velocity, and mean gradient, was not signifi-
cantly different between symptomatic and asymp-
tomatic patients. However, diastolic parameters of
E, e=, and E/e= ratio were significantly different. E
and E/e= ratio were significantly higher in the
symptomatic AS patients group versus the asymp-
tomatic AS patients group.
The study population was divided into 4 groups
based on their presenting major symptoms at base-
line (group I, asymptomatic [n  341, 68.5%],
vere AS (n=498)
rea <1 cm2 and normal LVEF
nd echocardiographic assessment
Chest Pain
(n=32, 6.4%)
Asymptomatic Severe AS
(n=341, 68.5%)Se
lve a
al agroup II, syncope [n  15, 3.0%]; group III,
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140dyspnea [n  110, 22.1%]; group IV, chest pain
[n  32, 6.4%]). In group III, 37 (34%) patients
lso had chest heaviness or chest discomfort.
When the patients were divided into 4 groups
Echocardiographic Findings in Severe AS Patients
Symptomatic Severe AS
(n  157)
Asymptomatic Severe AS
(n  341) p Value*
68.1 11.0 64.6 12.6 0.002
88 (56.1) 203 (59.5) 0.291
159.7 9.4 160.8 12.7 0.128
61.1 11.1 63.8 30.5 0.1
1.63 0.18 1.66 0.24 0.353
23.9 3.5 24.6 13.6 0.516
125.2 20.6 124.9 18.3 0.878
70.9 12.4 72.3 13.3 0.362
74.5 14.1 75.2 15.3 0.363
75 (47.8) 146 (42.8) 0.543
39 (24.8) 58 (17) 0.192
21 (13.4) 44 (12.9) 0.865
57.7 15.4 56.8 15.2 0.240
4.92 0.60 4.86 0.63 0.105
0.72 0.19 0.75 0.18 0.053
0.44 0.12 0.46 0.11 0.174
31.6 6.7 31.2 6.6 0.323
51.4 6.2 52.0 6.1 0.462
30.1 5.5 30.9 5.1 0.656
11.9 2.7 11.5 2.6 0.211
11.3 1.9 11.0 1.7 0.161
52.1 16.7 49.9 17.8 0.285
0.45 0.10 0.43 0.08 0.216
145.2 45.0 140.1 46.8 0.225
65.1 7.2 64.4 6.5 0.933
88.6 20.5 86.9 20.8 0.504
5.9 1.5 6.3 1.7 0.025
52.6 12.1 55.3 12.9 0.504
3.7 0.93 3.8 1.08 0.161
0.88 0.34 0.78 0.30 0.0008
0.97 0.30 0.96 0.30 0.648
0.95 0.46 0.85 0.52 0.066
0.047 0.02 0.057 0.02 <0.0001
19.5 6.83 14.1 4.67 <0.0001
n (%). Bold values are statistically signiﬁcant. *p  0.05 by Wilcoxon rank sum
pendent samples (continuous variable), chi-square test or Fisher exact test
elocity; AS aortic stenosis; AV aortic valve; AVA aortic valve area; AVAI
 body surface area; BMI body mass index; CI cardiac index; CO cardiac
ood pressure; DM  diabetes mellitus; E  early transmitral ﬂow velocity; e= 
ar velocity; E/e=  E/e’ ratio; EA  EA ratio; HR  heart rate; HT  hypertension;
lemia; IVSd  interventricular septal thickness; LAVI  left atrial volume index;
ction fraction; LVIDd  left ventricular end-diastolic dimension; LVIDS  left
ension; LVMI  left ventricular mass index; LVPWd  left ventricular posterior
aortic valve mean pressure gradient; RWT  relative wall thickness; SBP 
 stroke volume; SWL  stroke work loss; Vmax  aortic valve maximumased on presenting symptom(s) at baseline, there (ere no differences in their demographics, includ-
ng sex, body mass index, systolic and diastolic
lood pressures, heart rate, and comorbidities
Table 2). Baseline echocardiographic parameters of
groups are shown in Table 3. The severity of AS,
s determined by AVA, peak velocity, and mean
radient, was not significantly different among the 4
roups. There were no significant differences in LV
nd-systolic dimension, LV wall thickness, LV
ass index, relative wall thickness, and ejection
raction. However, group II (syncope) patients had
ignificantly smaller LV end-diastolic dimension,
ower stroke volume (SV), cardiac output, and left
trial volume index (LAVI) than did the other
roups (Table 3, Fig. 2). There was a significant
ifference between 4 groups regarding diastolic
ysfunction parameters of E velocity, e= velocity,
nd E/e= ratio. E velocity was highest and e=
elocity was lowest in group III with presenting
ymptom of dyspnea, resulting in the highest E/e=
i.e., estimated filling pressure) in that group. Con-
istent with preceding data, LAVI was largest in
roup III when compared to other groups. E/e=
atio was significantly lower in group II than that in
he other groups, indicating lower filling pressure in
atients presenting with syncope.
Among 498 patients, 259 patients had coronary com-
uted tomography angiography or coronary angiography
hat showed no significant coronary artery disease. Of
hose 259, 92 were symptomatic and 167 were asymp-
omatic. There were no differences in the demograph-
cs among the 4 groups. In this subgroup of patients
ith known normal coronary anatomy, results regard-
ng intracardiac hemodynamics and cardiac structures
ere the same as those found in the total patients.
When LAVI, SV, stroke volume index, and E/e= ratio
ere stratified by sex and median age in 4 different
roups, LAVI was smaller in group II and largest in
roup III, when compared to other groups, regardless of
ex and age (Fig. 3).
E/e= ratio was significantly lower in group II than
n other the groups, and it was highest in group III
egardless sex and age (Fig. 4).
By multiple logistic regression analysis, E/e=
atio, LAVI, cardiac output, and SV index were
ndependent determinants of presence of symptoms
n severe AS patients (Table 4). To assess the
ssociation of presence of dyspnea and clinical and
chocardiographic parameters, we used the gener-
lized logit model for nominal response data.
roup III (dyspnea) is the reference group. E/e=
atio was significantly different between group ITable 1. Clinical and
Age, yrs
Male
Height, cm
Weight, kg
BSA, m2
BMI, kg/m2
SBP, mm Hg
DBP, mm Hg
HR, beats/min
Comorbidities
HT
DM
HyperC
AV parameters
Mean PG, mm Hg
Vmax, m/s
AVA, cm2
AVAI, cm2/m2
SWL, %
Echo parameters
LVIDd, mm
LVIDs, mm
IVSd, mm
LVPWd, mm
LAVI, ml/m2
RWT
LVMI, g/m2
LVEF, %
SV, ml
CO, l/min
SV index, ml/m2
CI, l/min/m2
E, m/s
A, m/s
E/A
e’, m/s
E/e’
Values are mean  SD or
test for comparing 2 inde
(categorical variables).
A late transmitral ﬂow v
aortic valve area index; BSA
output; DBP  diastolic bl
early diastolic mitral annul
HyperC  hypercholestero
LVEF  left ventricular eje
ventricular end-systolic dim
wall thickness; mean PG 
systolic blood pressure; SVasymptomatic) and group III (dyspnea). Also, E/e=
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141ratio was significantly different between group IV
(chest pain) and group III (dyspnea). E/e= ratio was
an important factor influencing the presence of
Table 2. Clinical Characteristics in 4 Groups
Group I: Asymptomatic
(n  341)
Group II: Sync
(n  15)
Age, yrs 64.6 12.6 68.2 11.7
Male 203 (59.5) 10 (66.7)
Height, cm 160.8 12.7 161.2 8.9
Weight, kg 63.8 30.5 60.4 9.7
BSA, m2 1.66 0.24 1.63 0.16
BMI, kg/m2 24.6 13.6 23.2 2.6
SBP, mm Hg 124.9 18.3 122.0 20.3
DBP, mm Hg 72.3 13.3 73.7 9.0
HR, beats/min 75.2 15.3 75.7 14.0
Comorbidities
HT 146 (42.8) 5 (33.3)
DM 58 (17) 3 (20)
HyperC 44 (12.9) 1 (6.7)
Values are mean  SD or n (%). Bold values are statistically signiﬁcant. *p  0
(categorical variables).
DOE  dyspnea on exertion; other abbreviations as in Table 1.
Table 3. Echocardiographic Parameters in 4 Groups
Group I: Asymptomatic
(n  341)
Group II: S
(n  1
AV parameters
Mean PG, mm Hg 56.8 15.2 57.7
Vmax, m/s 4.86 0.63 4.93
AVA, cm2 0.75 0.18 0.71
AVAI, cm2/m2 0.46 0.11 0.43
SWL, % 31.2 6.6 33.1
Echo parameters
LVIDd, mm 52.0 6.1† 47.4
LVIDs, mm 30.9 5.1 27.9
IVSd, mm 11.5 2.6 12.0
LVPWd, mm 11.0 1.7 11.5
LAVI, ml/m2 49.9 17.8† 35.2
RWT 0.43 0.08† 0.49
LVMI, g/m2 140.1 46.8 129.3
LVEF, % 64.4 6.5 64.5
SV, ml 86.9 20.8 74.7
CO, l/min 6.3 1.7† 5.2
SV index, ml/m2 52.6 12.1 44.8
CI, l/min/m2 3.8 1.1 3.1
E, m/s 0.78 0.30 0.66
A, m/s 0.96 0.30 0.98
E/A 0.85 0.52 0.72
e’, m/s 0.057 0.02 0.056
E/e’ 14.1 4.67 14.2
Values are mean SD. Bold values are statistically signiﬁcant. *p 0.05 by Krus
group adjusted multiple comparison corrected by Dunnett.
Abbreviations as in Tables 1 and 2.dyspnea among the 4 different groups (group I,
asymptomatic; group II, syncope; group III, dys-
pnea; group IV, chest pain) (Table 5).
Group III: DOE
(n  110)
Group IV: Chest Pain
(n  32) p Value*
67.9 11.4 68.9 9.7 0.020
55 (50) 23 (71.9) 0.103
158.5 9.1 162.8 9.7 0.063
60.5 10.9 63.7 12.4 0.338
1.61 0.17 1.68 0.18 0.921
24.0 3.5 24.0 3.7 0.828
127.5 20.9 118.6 18.7 0.050
71.8 12.9 66.3 10.7 0.10
75.2 14.1 71.7 14.2 0.092
50 (45.5) 20 (62.5) 0.507
23 (23.7) 13 (13.4) 0.138
14 (12.7) 6 (18.8) 0.614
y Kruskal-Wallis test (continuous variable), chi-square test, or Fisher exact test
pe Group III: DOE
(n  110)
Group IV: Chest Pain
(n  32) p Value*
58.2 16.1 55.7 11.9 0.803
4.94 0.60 4.84 0.51 0.651
0.71 0.18 0.76 0.22 0.155
0.44 0.12 0.45 0.11 0.667
31.3 7.0 31.9 5.1 0.732
51.9 6.6† 51.6 4.8 0.043
30.3 5.9 30.5 4.3 0.141
11.9 3.0 11.8 1.5 0.499
11.3 2.1 11.4 1.3 0.369
54.1 16.5† 53.1 16.2† 0.003
0.44 0.11 0.44 0.06 0.058
148.6 48.9 141.3 36.7 0.306
65.3 7.6 64.9 6.0 0.647
89.0 19.4† 93.9 24.2† 0.044
5.8 1.4 6.4 1.9† 0.033
56.5 13.1† 56.2 11.0† 0.009
3.7 0.9 3.8 0.8 0.137
0.94 0.36† 0.80 0.27 <0.0001
0.99 0.32 0.90 0.26 0.492
0.98 0.48 0.93 0.46 0.074
0.044 0.01† 0.053 0.014 <0.0001
21.3 6.20† 15.8 6.39 <0.0001
allis test (continuous variable). †p 0.05 versus group II (syncope) as referenceope
.05 bynco
5)
17.5
0.80
0.19
0.10
7.4
4.2
3.8
2.1
1.4
7.8
0.09
24.2
6.8
14.6
1.0
10.8
0.6
0.18
0.23
0.31
0.03
6.67
kal-W
a on
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142D I S C U S S I O N
The principal finding of this study was that there is
a characteristic intracardiac hemodynamic profile
for each presenting symptoms (syncope, dyspnea,
and chest pain) in patients with severe AS, despite
LA
VI
 (m
l/m
2 )
A
Syncope DOE Chest Pain
0
20
40
60
80
100
SV
I (
ml
/m
2 )
B
Syncope
0
20
40
60
80
100
Figure 2. LAVI, SVI, and E/e= Ratio in Patients With Different Sy
(A) Left atrial volume index (LAVI); (B) stroke volume index (SVI); (C) E/e= r
senting as chest pain; DOE  symptomatic patients presenting as dyspne
LA
VI
, m
l/m
2
A   Male
0
20
40
60
80
48.1±
18.1
ASx
37.4±
8.2
P<0.05 P<0.05
P<0.05
Syncope
50.1±
15.8
DOE
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16.5
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VI
, m
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2
C   Age < 65.7
0
20
40
60
80
47.8±
18.8
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29.3±
3.7
P<0.05 P<0.05
P<0.05
Syncope
54.6±
17.9
DOE
55.4±
13.2
Chest Pain
Figure 3. LAVI in Patients With Different Symptoms Stratiﬁed b
(A) Male; (B) female; (C) age 65.7 years; (D) age 65.7 years. Valu
group. Adjusted multiple comparison corrected by Dunnett. ASx  asya similar AVA and aortic valve mean pressure
gradient. This result suggests that there are super-
imposed mechanisms for development of a partic-
ular symptom in patients with severe AS. Larger
LA volume, lower cardiac output, lower SV index,
and higher E/e= ratio were independent determi-
OE Chest Pain
E/
e’
C
Syncope DOE Chest Pain
0
10
20
30
40
oms
Data are listed as mean  SD. Chest pain  symptomatic patients pre-
exertion; syncope  symptomatic patients presenting as syncope.
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143nants of the presence of symptoms in our study
patients with severe AS. The patients who pre-
sented with dyspnea (group III) had the worst
diastolic function and the highest filling pressure,
evidenced by largest LA volume, lowest e=, highest
E, and highest E/e= ratio. On the other hand, the
patients who presented with syncope (group II)
Table 4. Independent Determinants of Presence of Symptoms i
Analysis of Maximum Likelihood Estim
Parameters DF Estimate Standard Error Wald Ch
Age, yrs 1 0.0205 0.0192 1.1
Male 1 0.0385 0.3136 0.0
BSA, m2 1 0.0183 0.0234 0.6
SBP, mm Hg 1 0.0188 0.0101 3.4
E/e= 1 0.2795 0.0494 32.0
LAVI, ml/m2 1 0.0223 0.0135 12.7
CO, l/min 1 0.7956 0.1885 17.8
SVI, ml/m2 1 0.0908 0.0249 13.2
p Value determined by multiple logistic regression analysis. Bold values are st
P<0.05
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Figure 4. E/e= Ratio in Patients With Different Symptoms Stratiﬁ
(A) Male; (B) female; (C) age 65.7 years; (D) age 65.7 years. Valu
group. Adjusted multiple comparison corrected by Dunnett. AbbrevCI  conﬁdence interval; DF  degrees of freedom; Pr  probability; other abbrewere found to have reduced SV and better preserved
diastolic function without increased filling pressure.
In the setting of hemodynamically significant
AS, the spectrum of diastolic abnormalities are
known to be present, including increased myocar-
dial stiffness, reduced LV compliance, increased LV
mass, and elevated LV end-diastolic and LA pa-
e Multiple Logistic Regression Analysis
Odds Ratio Estimates
uare Pr > Chi-Square Point Estimate 95% Wald CI
0.2861 1.021 0.983 1.06
0.9023 0.926 0.271 3.166
0.4328 0.982 0.938 1.028
0.0635 1.019 0.999 1.039
<0.0001 1.322 1.20 1.457
0.0092 0.978 1.052 1.114
<0.0001 0.451 0.312 0.653
0.0003 1.095 1.043 1.15
cally signiﬁcant.
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144rameters (6). Also, it has been shown that moderate
to severe diastolic dysfunction is an independent
predictor of increased morbidity and mortality in
patients with AS (11). Although Bruch et al. (12)
demonstrated impairment of diastolic function us-
ing tissue Doppler imaging in symptomatic patients
with advanced AS and LV hypertrophy, our study
demonstrates that the extent of diastolic dysfunc-
tion as well as SV and cardiac output appear to be
responsible for the presenting symptoms in this
group.
Role of ﬁlling pressures in patients with severe AS. In
atients with AS, diastolic dysfunction was ob-
erved in at least 50% of patients with preserved
ystolic function and in 100% of patients with
epressed function (13,14). Elevated filling pressure
Table 5. Association of Presence of Dyspnea in the Generalized
Analysis of Maximu
Parameter Groups* DF Estimate Standard Erro
Age I 1 0.0224 0.0222
II 1 0.025 0.0577
IV 1 0.019 0.0413
BSA I 1 0.00213 0.0315
II 1 0.0787 0.1092
IV 1 0.0466 0.0518
DBP I 1 0.0333 0.0178
II 1 0.0082 0.0574
IV 1 0.0663 0.0327
HR I 1 0.0174 0.0168
II 1 0.00612 0.0635
IV 1 0.0205 0.0321
DM I 1 1.0188 0.6275
II 1 1.0561 1.4618
IV 1 2.744 0.9405
LVIDd I 1 0.0569 0.0436
II 1 0.2963 0.1546
IV 1 0.0392 0.0822
LVMI I 1 0.00227 0.00402
II 1 0.000538 0.00964
IV 1 0.00105 0.00723
E/e= I 1 0.3531 0.0629
II 1 0.2346 0.1996
IV 1 0.3397 0.1034
LAVI I 1 0.0315 0.0148
II 1 0.0276 0.0575
IV 1 0.0424 0.0266
SVI I 1 0.0202 0.0177
II 1 0.1278 0.0708
IV 1 0.0013 0.0302
All p values were corrected by Bonferroni method due to multiple testing. *Gro
group IV  chest pain.
Abbreviations as in Tables 1 and 4.ay induce symptoms such as dyspnea under ixertion or even at rest resulting in pulmonary
enous congestion. Indeed, a previous study (15)
emonstrated that enhanced early diastolic filling
indicating increased filling pressure) distin-
uishes symptomatic from asymptomatic patients
ith AS.
In our study, LV filling pressure was estimated by
/e= ratio obtained from echocardiography. The
atio (E/e=) of early transmitral flow velocity (E) to
arly diastolic septal mitral annular velocity (e=) has
een shown to be a reliable noninvasive method of
stimation of LV filling pressure (16–18). Increased
alue of E/e= ratio accurately predicted elevated
lling pressures in moderate to severe AS (12), and
he E/e= ratio has been reported to predict the
rognosis of patients in a variety of cardiac diseases
it Model for Nominal Response Data
ikelihood Estimates
Wald Chi-Square Pr > Chi-Square Adjusted p Value
1.0188 0.3128 0.938
0.1881 0.6645 1.000
0.2113 0.6458 1.000
0.0046 0.946 1.000
0.5197 0.471 1.000
0.8076 0.3688 1.000
3.4963 0.0615 0.185
0.0205 0.8863 1.000
4.098 0.0429 0.129
1.0725 0.3004 0.901
0.0093 0.9233 1.000
0.4099 0.522 1.000
2.6355 0.1045 0.313
0.522 0.47 1.000
8.5128 0.0035 0.011
1.705 0.1916 0.575
3.672 0.0553 0.166
0.2278 0.6331 1.000
0.3193 0.5721 1.000
0.0031 0.9555 1.000
0.0212 0.8842 1.000
31.5473 <0.0001 <0.0001
1.3809 0.2399 0.720
10.7869 0.001 0.003
4.4984 0.0339 0.102
0.2302 0.6314 1.000
2.5366 0.1112 0.334
1.3093 0.2525 0.758
3.2564 0.0711 0.213
0.0018 0.9658 1.000
 asymptomatic; group II  syncope; group III  dyspnea (reference group);Log
m L
r
up Including AS (19–22).
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145Our present study demonstrated an important
relationship between diastolic dysfunction and typ-
ical symptoms in severe AS. Our group has shown
that increased E/e= ratio was an independent pre-
ictor of outcome even after aortic valve replace-
ent in patients symptomatic severe AS (22). The
orse diastolic dysfunction and higher estimated
lling pressure in dyspnea group are most likely due
o coexisting myocardial abnormality in addition to
evere AS, because diastolic dysfunction is relatively
ommon in the elderly even without aortic valve
tenosis or LV hypertrophy. This provides a possi-
le explanation for the worse prognosis found in
atients with higher E/e= after aortic valve replace-
ment. The onset of angina, syncope, and dyspnea
has been shown to correlate with an average time to
death of 5, 3, and 2 years, respectively (23). This
clinical course has been derived primarily from
postmortem studies on adults with acquired AS
(23). The clinical spectrum of AS is broad, and
patients with the same AVA can have different
symptoms and intracardiac hemodynamics. Our
data emphasize the importance of diastolic dysfunc-
tion in the natural history and its role in presenting
symptoms of patients with severe AS. Because
diastolic dysfunction is a common abnormality in
the elderly even without AS, it is possible that those
patients with pre-existing diastolic dysfunction or
who are susceptible for diastolic dysfunction inde-
pendent of AS are more likely present with dys-
pnea. Such patients may present with dyspnea even
in the setting of nonsevere AS. It will be helpful if
future investigations can address the question of
whether aortic valve replacement can improve
symptoms and survival of the patients with dyspnea
and less than severe AS. This study also emphasizes
the importance of assessing diastolic function as
well as SV as a part of evaluation of AS, because
they are intimately related to the patient’s present-
ing symptoms and clinical outcome.
Study limitations. Several potential limitations in
ur study must be noted. First, the number of
atients with syncope was relatively small. How-
ver, syncope is a less frequent symptom than
yspnea or chest pain. Despite the small number,
ur finding that decreased stroke volume and rela-
ively lower filling pressure are responsible for
yncope is an important observation. Increased
lling pressure may be necessary to compensate for
asodilation when it occurs in patients with severe
S. Second, the patients with coronary artery
isease were not included in our study. In the
resence of coronary artery disease, chest pain may oe more common when increased filling pressure
an induce myocardial ischemia and/or ventricular
rrhythmias. Therefore, intracardiac hemodynamic
haracteristics may be different in patients with
evere AS and coronary artery disease. Third, the
umber of patients with syncope or chest pain was
elatively small compared with the number of pa-
ients with dyspnea. This relatively small number
ight have introduced a possibility of selection bias.
ourth, the patients with LV systolic dysfunction
ere not included in our study to avoid hemody-
amic changes related to LV systolic dysfunction.
herefore, our study results are not applicable to
he patients with LV systolic dysfunction. Fifth, all
ntracardiac hemodynamics and AS severity were
erived from echocardiographic measurements that
an be operator- and patient-dependent. However,
hese noninvasive hemodynamic parameters have
een well validated (8).
Finally, this study was conducted in a single
eferral tertiary hospital with a cardiac imaging
enter. Many patients of our study were referred for
valuation of murmur from other smaller hospitals.
hose patients did not have any symptoms except
or murmur. In addition, the exclusion of patients
ith coronary artery disease may have contributed
o a large number of asymptomatic patients. There-
ore, numbers of asymptomatic patients were rela-
ively high.
C O N C L U S I O N S
In patients with anatomically severe AS, develop-
ment of a particular symptom is linked to specific
hemodynamic patterns. In the patients with severe
AS who develop dyspnea, markedly altered LV
diastolic function with increased filling pressure was
present. On the other hand, the patients who
develop syncope present with reduced SV along
with smaller LV and LA. Hence, comprehensive
intracardiac hemodynamics including diastolic
function need to be evaluated in addition to AVA
and pressure gradient for assessment of AS.
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